查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768552

全球混合成像市场

Hybrid Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 231 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球混合成像市场规模将达到 134 亿美国

全球混合成像市场规模预计在2024年为101亿美元，预计到2030年将达到134亿美元，2024年至2030年的复合年增长率为4.9%。 PET/CT系统是本报告分析的细分市场之一，预计其复合年增长率为4.9%，到分析期结束时规模将达到47亿美元。 SPET/CT系统细分市场在分析期间的复合年增长率预计为5.5%。

美国市场预计将达到 28 亿美元，中国市场复合年增长率将达到 4.7%

美国混合成像市场规模预计2024年达到28亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到21亿美元，在2024-2030年的分析期间内，复合年增长率为4.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.5%和4.1%。在欧洲，预计德国市场的复合年增长率为4.8%。

全球混合成像市场－主要趋势与驱动因素摘要

混合影像将如何彻底改变医学诊断？

混合影像代表了医学诊断领域的一项重大进步，它结合了两种或多种显像模式，例如正子断层扫描 (PET) 和磁振造影(MRI)，从而提供更全面的诊断资讯。这些混合系统透过在单次扫描中提供功能性和解剖性数据，提高了疾病的检测、诊断和监测能力。例如，PET-MRI 提供出色的软组织对比度和功能性影像，这对于检测癌症、神经系统疾病和心血管疾病至关重要。不同影像技术的整合可以实现更准确的诊断、改进治疗方案并改善患者预后，使混合成像成为现代医疗保健的重要工具。

技术进步如何影响混合成像市场？

技术创新在混合成像系统的演进中发挥关键作用。检测器技术、影像重建演算法和资料处理的进步提高了混合成像设备的精度和速度。例如，数位检测器的发展提高了PET-CT和SPECT-CT系统的灵敏度和分辨率，从而带来了更清晰的影像和更早的疾病发现。此外，人工智慧驱动的影像分析工具正在整合到混合成像工作流程中，从而加快了影像解读速度并提高了诊断准确性。混合成像系统也变得更加紧凑和便捷，透过扩大其在门诊和小型医疗机构中的应用，扩大了市场基础。

市场区隔将如何影响混合成像市场的成长？

影像方式包括正子断层扫描（PET-CT）、正子断层磁振造影（PET-MRI）和单光子发射断层扫描（SPECT-CT），其中PET-CT占据最大市场占有率，因为它广泛应用于肿瘤学，用于肿瘤检测和治疗监测。混合影像的应用领域广泛，包括肿瘤科、神经科、心臟科和骨科。由于全球癌症发生率不断上升，肿瘤科成为其主要应用领域。最终用户包括医院、影像中心和研究机构，其中医院凭藉其先进的影像基础设施占据最大市场占有率。个人化医疗应用也在成长，其中混合影像用于评估治疗效果和客製化治疗方案。

哪些因素推动了混合成像市场的成长？

混合影像市场的成长受到多种因素的推动，例如慢性病盛行率的上升、影像技术的进步以及对早期精准诊断日益增长的需求。随着全球癌症、心血管疾病和神经系统疾病负担的不断加重，医疗保健提供者正转向混合成像，以提高诊断准确性和治疗决策。人工智慧和机器学习在影像处理中的整合提高了混合成像系统的准确性和效率，提升了其在临床环境中的价值。此外，个人化医疗的兴起和发展中地区医疗基础设施的不断扩张，也推动了对混合成像技术的需求。

部分

类型（PET/CT 系统、SPET/CT 系统、PET/MR 系统、OCT/眼底影像系统、其他类型）、应用（肿瘤学、眼科学、循环系统、神经病学、其他应用）、最终用途（医院、诊断影像中心、其他最终用途）

受访公司范例

  • Bruker
  • Canon Medical Systems Corp.
  • Cubresa, Inc.
  • Fujifilm VisualSonics, Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Mediso Ltd.
  • MILabs BV
  • MR Solutions
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • TriFoil Imaging

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP21999

Global Hybrid Imaging Market to Reach US$13.4 Billion by 2030

The global market for Hybrid Imaging estimated at US$10.1 Billion in the year 2024, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. PET / CT Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the SPET / CT Systems segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 4.7% CAGR

The Hybrid Imaging market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Hybrid Imaging Market - Key Trends and Drivers Summarized

Why Is Hybrid Imaging Revolutionizing Medical Diagnostics?

Hybrid imaging represents a significant advancement in medical diagnostics by combining two or more imaging modalities, such as Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI), to provide more comprehensive diagnostic information. These hybrid systems enhance the ability to detect, diagnose, and monitor diseases by offering both functional and anatomical data in a single scan. For instance, PET-MRI provides superior soft-tissue contrast and functional imaging, which is critical for detecting cancer, neurological disorders, and cardiovascular diseases. The integration of different imaging technologies allows for more accurate diagnoses, improved treatment planning, and better patient outcomes, making hybrid imaging an indispensable tool in modern healthcare.

How Are Technological Advancements Shaping the Hybrid Imaging Market?

Technological innovations are playing a pivotal role in the evolution of hybrid imaging systems. Advances in detector technologies, image reconstruction algorithms, and data processing have improved the precision and speed of hybrid imaging devices. For example, the development of digital detectors has enhanced the sensitivity and resolution of PET-CT and SPECT-CT systems, leading to sharper images and earlier disease detection. Moreover, AI-driven image analysis tools are increasingly being integrated into hybrid imaging workflows, allowing for faster interpretation and improved diagnostic accuracy. Hybrid imaging systems are also becoming more compact and accessible, which is expanding their use in outpatient clinics and smaller healthcare facilities, broadening the market's reach.

How Do Market Segments Influence the Growth of the Hybrid Imaging Market?

Modalities include PET-CT, PET-MRI, and SPECT-CT, with PET-CT holding the largest market share due to its widespread use in oncology for tumor detection and treatment monitoring. Applications of hybrid imaging span across oncology, neurology, cardiology, and orthopedics, with oncology being the dominant application area due to the increasing global burden of cancer. End-users include hospitals, diagnostic imaging centers, and research institutions, with hospitals accounting for the largest market share because of their advanced imaging infrastructure. The market is also witnessing growth in personalized medicine applications, where hybrid imaging is used to assess treatment efficacy and tailor therapeutic approaches.

What Factors Are Driving the Growth in the Hybrid Imaging Market?

The growth in the hybrid imaging market is driven by several factors, including the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing demand for early and accurate diagnosis. As the global burden of cancer, cardiovascular diseases, and neurological disorders continues to rise, healthcare providers are increasingly relying on hybrid imaging to improve diagnostic precision and guide treatment decisions. The integration of AI and machine learning in image processing is enhancing the accuracy and efficiency of hybrid imaging systems, making them more valuable in clinical settings. Additionally, the growing adoption of personalized medicine and the expansion of healthcare infrastructure in developing regions are fueling the demand for hybrid imaging technologies.

SCOPE OF STUDY:

The report analyzes the Hybrid Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System, Other Types); Application (Oncology, Ophthalmology, Cardiology, Brain & Neurology, Other Applications); End-Use (Hospitals, Diagnostic Imaging Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Bruker
  • Canon Medical Systems Corp.
  • Cubresa, Inc.
  • Fujifilm VisualSonics, Inc.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • TriFoil Imaging

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Hybrid Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Multi-Modal Imaging in Diagnostics Propels Growth in Hybrid Imaging
    • Technological Advancements in PET-CT and SPECT-CT Strengthen the Business Case for Hybrid Imaging
    • Increasing Adoption of Hybrid Imaging in Oncology and Cardiology Expands Addressable Market
    • Growing Focus on Early Disease Detection and Precision Medicine Drives Demand for Hybrid Imaging Systems
    • Government Initiatives to Improve Healthcare Infrastructure Spur Market Adoption of Hybrid Imaging
    • Rising Interest in Personalized and Non-Invasive Diagnostic Solutions Fuels Hybrid Imaging Demand
    • Expansion of Hybrid Imaging Applications in Neurology and Orthopedics Creates New Market Opportunities
    • Integration of AI and Machine Learning in Hybrid Imaging Accelerates Market Innovation
    • Growing Focus on Reducing Diagnostic Errors Strengthens the Case for Hybrid Imaging
    • Rising Prevalence of Chronic Diseases and Aging Population Drives Demand for Hybrid Imaging Solutions
    • Increasing Adoption of Mobile and Portable Hybrid Imaging Devices Creates New Opportunities
    • Technological Innovations in Image Fusion and Resolution Enhance the Efficiency of Hybrid Imaging Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hybrid Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hybrid Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Hybrid Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Brain & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Hybrid Imaging Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for PET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for SPET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for SPET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for SPET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for PET / MR Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for OCT / Fundus Imaging System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for OCT / Fundus Imaging System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for OCT / Fundus Imaging System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Hybrid Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Hybrid Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION